Table 2 Ranges of the mean and one standard deviation (SD) of the dose volume histogram metrics over10 breathing phases in13 patients. All plans were prescribed by coverage according to ICRU 91

D₉₈ (Gy)

55.7–62.5 (0.65)

0.3–1.0 (1.00)

55.5–62.2 (0.32)

0.2–1.8 (0.91)

55.0–61.5 (0.96)

0.3–1.1 (0.99)

54.8–60.5 (0.90)

0.2–1.2 (0.70)

D₅₀ (Gy)

59.6–68.3 (0.38)

0.1–0.3 (1.00)

60.0–65.8 (0.58)

0.1–0.8 (1.00)

59.7–67.6 (0.82)

0.1–0.3 (1.00)

56.4–65.1 (0.84)

0.1–0.5 (1.00)

D₂ (Gy)

64.9–73.6 (0.32)

0.0–0.6 (1.00)

61.2–70.5 (< 0.05)

0.0–0.7 (1.00)

61.6–72.5 (0.42)

0.0–0.3 (1.00)

60.6–70.6 (0.43)

0.0–0.5 (1.00)

V_30Gy (cm³)

9.3–73.1 (<  0.01)

0.7–5.3 (1.00)

2.8–39.9 (<  0.01)

0.8–4.8 (1.00)

1.6–31.6 (<  0.01)

0.3–4.4 (1.00)

1.8–29.9 (<  0.01)

0.3–3.8 (1.00)

V_5Gy (cm³)

9.4–29.0 (0.06)

0.1–1.7 (0.91)

9.8–25.9 (<  0.05)

0.1–1.9 (1.00)

8.6–27.8 (< 0.05)

0.1–2.0 (1.00)

8.0–27.0 (0.09)

0.1–2.0 (1.00)

V_20Gy (cm³)

3.6–15.1 (0.16)

0.1–3.7 (1.00)

3.8–14.8 (0.09)

0.1–1.3 (1.00)

3.3–14.8 (0.07)

0.1–1.2 (1.00)

3.0–14.0 (0.15)

0.1–1.3 (1.00)

MLD (Gy)

2.3–8.3 (<  0.01)

0.0–0.6 (1.00)

2.4–7.9 (<  0.01)

0.0–0.5 (1.00)

2.2–7.8 (<  0.01)

0.0–0.5 (1.00)

2.0–7.4 (<  0.01)

0.0–0.5 (1.00)